Clearpoint Neuro Inc expected to post a loss of 19 cents a share - Earnings Preview
04/05/2024 03:04
* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected
to show a
rise in quarterly revenue when it reports results on May 7 for
the period ending March 31 2024
* The Solana Beach California-based company is expected to
report
a 28.7% increase in revenue to $6.994 million from $5.43 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Clearpoint Neuro Inc is
for a
loss of 19 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $10.00, above its last closing price of $5.87.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.18 -0.20 -0.19 Beat 6.6
Sep. 30 2023 -0.25 -0.25 -0.20 Beat 20
Jan. 1 0001 -0.19 -0.19 -0.29 Missed -52.6
Mar. 31 2023 -0.18 -0.18 -0.23 Missed -24.3
Dec. -0.20 -0.20 -0.18 Beat 10
31 2022
Sep. 30 2022 -0.19 -0.19 -0.15 Beat 21.1
Jun. 30 2022 -0.18 -0.18 Met 1.4
Mar. 31 2022 -0.20 -0.20 -0.17 Beat 15
This summary was machine generated May 4 at 02:04 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)